Clinical Trials
Closed
Phase
Published
SWOG Clinical Trial Number
SWOG-8319
Evaluation of Fludarabine Phosphate in Ovarian Cancer
Activated
06-01-1984
Closed
06-30-1986
Closed
Phase
Published
SWOG Clinical Trial Number
SWOG-8328
Evaluation of Fludarabine Phosphate in Cervical Cancer
Activated
06-01-1984
Closed
03-18-1987
Closed
Phase
Published
SWOG Clinical Trial Number
SWOG-8320
Evaluation of Fludarabine Phosphate in Endometrial Cancer
Activated
06-01-1984
Closed
03-01-1988
Closed
Phase
Published
SWOG Clinical Trial Number
SWOG-8461
Registration and Evaluation of Patients Aged 55 and Over with Unfavorable Histology NHL
Activated
06-01-1984
Closed
03-20-1986
Closed
Phase
Published
SWOG Clinical Trial Number
SWOG-8323
Evaluation of Fludarabine Phosphate in Advanced Mycosis Fungoides
Activated
05-21-1984
Closed
05-15-1988
Closed
Phase
Published
SWOG Clinical Trial Number
SWOG-8322
Evaluation of Fludarabine Phosphate in Advanced Sarcomas
Activated
05-11-1984
Closed
10-01-1986
Closed
Phase
Accrual
96%
Published
SWOG Clinical Trial Number
SWOG-8312
Megestrol Acetate and Aminoglutethimide/ Hydrocortisone In Sequence or in Combination as Second-Line Endocrine Therapy of Estrogen Receptor Positive Metastatic Breast Cancer
Research Committee(s)
Breast Cancer
Activated
05-04-1984
Closed
11-15-1990
Closed
Phase
Published
SWOG Clinical Trial Number
SWOG-8316
Evaluation of Fludarabine Phosphate in Renal Cell Carcinoma
Activated
04-20-1984
Closed
03-22-1985
Closed
Phase
Accrual
100%
Published
SWOG Clinical Trial Number
SWOG-8313 (EST 5186)
Multiple Drug Adjuvant Chemotherapy for Patients with ER Negative Stage II Carcinoma of Breast
Activated
04-20-1984
Closed
06-15-1990
Closed
Phase
Published
SWOG Clinical Trial Number
SWOG-8390
Chemotherapy of Gastric Cancer with 5-Fluorouracil (5-FU) and Folinic Acid
Activated
03-16-1984
Closed
03-01-1988
Closed
Phase
Published
SWOG Clinical Trial Number
SWOG-8385
Combination Chemotherapy with Cis-Platinum, Vinblastine and Methyl Glyoxal Bis (Guanylhydrazone)(MGBG) in Non-Small Cell Lung Cancer
Activated
02-24-1984
Closed
03-22-1985
Closed
Phase
SWOG Clinical Trial Number
SWOG-8375
Closed
Phase
Published
SWOG Clinical Trial Number
SWOG-8325
Combination Chemotherapy With O,P'-DDD and Cis-Platinum in Metastatic Adrenal Carcinoma
Activated
01-19-1984
Closed
07-01-1989
Closed
Phase
Published
SWOG Clinical Trial Number
SWOG-8386
Evaluation of Fludarabine Phosphate in Colorectal Carcinoma TEMPORARILY CLOSED: 8/17/84
Activated
01-19-1984
Closed
03-22-1985
Closed
Phase
Published
SWOG Clinical Trial Number
SWOG-8361
Treatment of Non-Hodgkin's Lymphoma of Intermediate and High Grade Malignancy with CHOP Chemotherapy and Systemic (TB vs. HB) Radiotherapy
Activated
01-03-1984
Closed
03-20-1986
Closed
Phase
Published
SWOG Clinical Trial Number
SWOG-8371
Evaluation of Diamine (1,1-Cyclobutane-Dicarboxylato-(2)-0,0')-CSP-4-2)Platinum (CBDCA-NSC-241240) and Cis-Dichloro-Trans-Dihydroxy-Bis-(Isoprpylamine)-Platinum IV (CHIP-NSC-256927) for Patients with Advanced (M1) and Recurrent Squamous Cell Cancer of the Head and Neck
Activated
12-22-1983
Closed
09-27-1985
Closed
Phase
SWOG Clinical Trial Number
SWOG-8378
Evaluation of Fludarabine Phosphate in Chronic Lympho- cytic Leukemia
Activated
12-05-1983
Closed
06-15-1987
Closed
Phase
Published
SWOG Clinical Trial Number
SWOG-8367
Combined Modality Treatment of Regional Non-Small Lung Cancer
Activated
12-01-1983
Closed
10-01-1986
Closed
Phase
Published
SWOG Clinical Trial Number
SWOG-8240
Evaluation of Spiorgermanium (NSC-192965) in the Treatment of Metastatic Malignant Melanoma
Activated
11-14-1983
Closed
05-31-1986
Closed
Phase
Accrual
100%
SWOG Clinical Trial Number
SWOG-8366
Cell Kinetic Measurement In Stage I and Stage II Node Negative or Node Positive (Pathological Stage T1-3, NO-1, MO) Breast Cancer, A Natural History Study
Activated
11-14-1983
Closed
11-01-1989